Influencing ICER: A Review of Manufacturer Involvement in ICER Assessments

Influencing ICER: A Review of Manufacturer Involvement in ICER Assessments

  • ISPOR 2019 New Orleans
  • Jun 2019
Real-World Evidence on the Rise: Evaluating the Use of Real-World Evidence in ICER Assessments of Comparative Clinical Effectiveness

Real-World Evidence on the Rise: Evaluating the Use of Real-World Evidence in ICER Assessments of Comparative Clinical Effectiveness

  • ISPOR 2019 New Orleans
  • May 2019
Patient, Payer and Manufacturer Perspectives on Four Cost-Control Mechanisms for Pharmaceuticals

Patient, Payer and Manufacturer Perspectives on Four Cost-Control Mechanisms for Pharmaceuticals

  • ISPOR 2019 New Orleans
  • May 2019
Bundled Payments for Care Improvement Advanced (BPCI-A): An Analysis of Public Communications During the Application Period

Bundled Payments for Care Improvement Advanced (BPCI-A): An Analysis of Public Communications During the Application Period

  • ISPOR 2019 New Orleans
  • May 2019
What’s Trending? Pharmacoeconomic Publications in the US between 2009–2018

What’s Trending? Pharmacoeconomic Publications in the US between 2009–2018

  • ISPOR 2019 New Orleans
  • May 2019
Framework Synthesis (FS) of Qualitative and Quantitative Evidence to Explore the Differential Diagnosis (DDx) of Diarrhea in Neuroendocrine Tumor (NET) Patients

Framework Synthesis (FS) of Qualitative and Quantitative Evidence to Explore the Differential Diagnosis (DDx) of Diarrhea in Neuroendocrine Tumor (NET) Patients

  • ISPOR 2019 New Orleans
  • May 2019
Expansion of State Medicaid Programs: Increased Patient Access to Opioid Replacement Therapy?

Expansion of State Medicaid Programs: Increased Patient Access to Opioid Replacement Therapy?

  • ISPOR 2019 New Orleans
  • May 2019
Vax-The-Nation: A Budget Impact Analysis of Costs Associated with Measles Outbreaks in the USA Through Increasing Measles, Mumps and Rubella Vaccination Uptake

Vax-The-Nation: A Budget Impact Analysis of Costs Associated with Measles Outbreaks in the USA Through Increasing Measles, Mumps and Rubella Vaccination Uptake

  • ISPOR 2019 New Orleans
  • May 2019
How do Patients and Caregivers Access Scientific Literature?

How do Patients and Caregivers Access Scientific Literature?

  • ISMPP EU 2019
  • Feb 2019
Are Results from Human Factors Studies Communicated Consistently and Transparently?

Are Results from Human Factors Studies Communicated Consistently and Transparently?

  • ISMPP EU 2019
  • Feb 2019
Defining ‘White Paper’ Publications in the Peer-Reviewed Medical Literature

Defining ‘White Paper’ Publications in the Peer-Reviewed Medical Literature

  • ISMPP EU 2019
  • Feb 2019
Who’s Who in Rare Diseases: A Case Study in Author Identification

Who’s Who in Rare Diseases: A Case Study in Author Identification

  • ISMPP EU 2019
  • Feb 2019
Loading